1.Crohn病の内科治療

Crohn病は原因不明で,外科的な対処を行っても再燃を繰り返し進行していく疾患であることから,内科的管理が治療戦略の中心となる.本邦では依然として栄養療法が主流ではあるが,抗TNF-α抗体療法の導入以来,薬物療法も普及している.新たな生物学的製剤,白血球除去療法,内視鏡的拡張術などにも期待が寄せられている.従来からの栄養療法と新しい薬物療法を上手く組み合わせて患者のQOL(quality of life)向上に努めなければならない....

Full description

Saved in:
Bibliographic Details
Published in日本内科学会雑誌 Vol. 98; no. 1; pp. 82 - 87
Main Authors 松本, 主之, 飯田, 三雄, 古賀, 秀樹
Format Journal Article
LanguageJapanese
Published 一般社団法人 日本内科学会 2009
Subjects
Online AccessGet full text
ISSN0021-5384
1883-2083
DOI10.2169/naika.98.82

Cover

Abstract Crohn病は原因不明で,外科的な対処を行っても再燃を繰り返し進行していく疾患であることから,内科的管理が治療戦略の中心となる.本邦では依然として栄養療法が主流ではあるが,抗TNF-α抗体療法の導入以来,薬物療法も普及している.新たな生物学的製剤,白血球除去療法,内視鏡的拡張術などにも期待が寄せられている.従来からの栄養療法と新しい薬物療法を上手く組み合わせて患者のQOL(quality of life)向上に努めなければならない.
AbstractList Crohn病は原因不明で,外科的な対処を行っても再燃を繰り返し進行していく疾患であることから,内科的管理が治療戦略の中心となる.本邦では依然として栄養療法が主流ではあるが,抗TNF-α抗体療法の導入以来,薬物療法も普及している.新たな生物学的製剤,白血球除去療法,内視鏡的拡張術などにも期待が寄せられている.従来からの栄養療法と新しい薬物療法を上手く組み合わせて患者のQOL(quality of life)向上に努めなければならない.
Author 古賀, 秀樹
飯田, 三雄
松本, 主之
Author_xml – sequence: 1
  fullname: 松本, 主之
  organization: 九州大学大学院病態機能内科学
– sequence: 1
  fullname: 飯田, 三雄
  organization: 九州大学大学院病態機能内科学
– sequence: 1
  fullname: 古賀, 秀樹
  organization: 九州大学大学院病態機能内科学
BookMark eNo9j71KxEAUhQdZwbhuZekzJM6dO5PcaQQJ6goLNloPs8mMm7hmJdnGUmEtha3EJ7CzsHXfRjSlr2D8wVOcU3zwwdlkvWpWOca2gUcCYr1b2eLCRpoiEmssACIMBSfssYBzAaFCkhts0DTFmEuMFQHKgO3A5-o-rWeTqn1YvN08v98t2qflx8tr-3i7xda9nTZu8Ld9dnZ4cJoOw9HJ0XG6PwpLSMiGSSfjvLOTz5WFTOQOfYxj9Erl6B0kueKJxMyDBi1jIbtonyO3Wnvk2Gd7v96ymdtzZ67q4tLW18bW8yKbOvNzzGgy8F0k_kE2sbUpLX4B6XhQng
ContentType Journal Article
Copyright 2009 一般社団法人 日本内科学会
Copyright_xml – notice: 2009 一般社団法人 日本内科学会
DOI 10.2169/naika.98.82
DatabaseTitleList
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1883-2083
EndPage 87
ExternalDocumentID article_naika_98_1_98_82_article_char_ja
GroupedDBID 2WC
ALMA_UNASSIGNED_HOLDINGS
DIK
F5P
JSF
OK1
RJT
ZXP
ID FETCH-LOGICAL-j178a-7365003848fd5a1c2de3f63b3f55d3fe17d50743cf191946244449fd30a99f303
ISSN 0021-5384
IngestDate Wed Sep 03 06:29:57 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed false
IsScholarly true
Issue 1
Language Japanese
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-j178a-7365003848fd5a1c2de3f63b3f55d3fe17d50743cf191946244449fd30a99f303
OpenAccessLink https://www.jstage.jst.go.jp/article/naika/98/1/98_82/_article/-char/ja
PageCount 6
ParticipantIDs jstage_primary_article_naika_98_1_98_82_article_char_ja
PublicationCentury 2000
PublicationDate 2009
PublicationDateYYYYMMDD 2009-01-01
PublicationDate_xml – year: 2009
  text: 2009
PublicationDecade 2000
PublicationTitle 日本内科学会雑誌
PublicationTitleAlternate 日内会誌
PublicationYear 2009
Publisher 一般社団法人 日本内科学会
Publisher_xml – name: 一般社団法人 日本内科学会
References 2) Takagi S, et al: Effectiveness of an half elemental diet as maintenance therapy for Crohn's disease: a randomized-controlled trial. Aliment Pharmacol Ther 24: 1333-1340, 2006.
1) 飯田三雄, 松本主之: クローン病の治療指針. 臨牀消化器内科 23: 599-606, 2008.
10) Irving PM, et al: Review article: appropriate use of corticosteroids in Crohn's disease. Aliment Pharmacol Ther 26: 313-329, 2007.
6) D'Haens G, et al: Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial. Lancet 371: 660-667, 2008.
4) Matsumoto T, et al: Therapeutic efficacy of infliximab on active Crohn's disease under nutritional therapy. Scand J Gastroenterol 40: 1423-1430, 2005.
8) van Assche G, et al: Withdrawal of immunosuppression in Crohn's disease treated with scheduled infliximab maintenance: a randomized trial. Gastroenterology 134: 1861-1868, 2008.
7) Rosh JR, et al: Hepatosplenic T-cell lymphoma in adolescents and young adults with Crohn's disease: a cautionary tale? Inflamm Bowel Dis 13: 1024-1030, 2007.
5) Holtmann MH, et al: Long-term effectiveness of azathioprine in IBD beyond 4 years: a European multicenter study in 1176 patients. Dig Dis Sci 51: 1516-1524, 2006.
3) Esaki M, et al: Factors affecting recurrence in patients with Crohn's disease under nutritional therapy. Dis Colon Rectum 49: 568-574, 2006.
9) Colombel JF, et al: A controlled trial comparing ciprofloxacin with mesalazine for the treatment of active Crohn's disease. Am J Gastroenterol 94: 674-678, 1999.
11) Bergman R, Parkes M: Systematic review: the use of mesalazine in inflammatory bowel disease. Aliment Pharmacol Ther 23: 841-855, 2006.
References_xml – reference: 2) Takagi S, et al: Effectiveness of an half elemental diet as maintenance therapy for Crohn's disease: a randomized-controlled trial. Aliment Pharmacol Ther 24: 1333-1340, 2006.
– reference: 1) 飯田三雄, 松本主之: クローン病の治療指針. 臨牀消化器内科 23: 599-606, 2008.
– reference: 9) Colombel JF, et al: A controlled trial comparing ciprofloxacin with mesalazine for the treatment of active Crohn's disease. Am J Gastroenterol 94: 674-678, 1999.
– reference: 3) Esaki M, et al: Factors affecting recurrence in patients with Crohn's disease under nutritional therapy. Dis Colon Rectum 49: 568-574, 2006.
– reference: 7) Rosh JR, et al: Hepatosplenic T-cell lymphoma in adolescents and young adults with Crohn's disease: a cautionary tale? Inflamm Bowel Dis 13: 1024-1030, 2007.
– reference: 10) Irving PM, et al: Review article: appropriate use of corticosteroids in Crohn's disease. Aliment Pharmacol Ther 26: 313-329, 2007.
– reference: 4) Matsumoto T, et al: Therapeutic efficacy of infliximab on active Crohn's disease under nutritional therapy. Scand J Gastroenterol 40: 1423-1430, 2005.
– reference: 5) Holtmann MH, et al: Long-term effectiveness of azathioprine in IBD beyond 4 years: a European multicenter study in 1176 patients. Dig Dis Sci 51: 1516-1524, 2006.
– reference: 11) Bergman R, Parkes M: Systematic review: the use of mesalazine in inflammatory bowel disease. Aliment Pharmacol Ther 23: 841-855, 2006.
– reference: 6) D'Haens G, et al: Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial. Lancet 371: 660-667, 2008.
– reference: 8) van Assche G, et al: Withdrawal of immunosuppression in Crohn's disease treated with scheduled infliximab maintenance: a randomized trial. Gastroenterology 134: 1861-1868, 2008.
SSID ssib043658134
ssj0066765
ssib002821954
ssib005879745
ssib007485360
ssib058493862
ssib000940260
ssib002484664
Score 1.7932143
Snippet Crohn病は原因不明で,外科的な対処を行っても再燃を繰り返し進行していく疾患であることから,内科的管理が治療戦略の中心となる.本邦では依然として栄養療法が主...
SourceID jstage
SourceType Publisher
StartPage 82
SubjectTerms Crohn病
Crohn病治療指針
栄養療法
薬物療法
Title 1.Crohn病の内科治療
URI https://www.jstage.jst.go.jp/article/naika/98/1/98_82/_article/-char/ja
Volume 98
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX 日本内科学会雑誌, 2009, Vol.98(1), pp.82-87
journalDatabaseRights – providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 1883-2083
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssib007485360
  issn: 0021-5384
  databaseCode: KQ8
  dateStart: 19130101
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Pi9QwFA_rCuJF_Iu6KnvwnaTjpEmal2M622ERVhB2YW9lpm2QOczKMnvxprAeBU_iJ_Dmwat-G9E5-hV8SdtpR_ewLgwhk7y8vOSlfb-kyQtjj4fxlHCITiJXuSSSJfLIOD6JCkfGoKIphYz94eS958nugXx2qA43LmFv19LJYjooXp95ruQiWqU00qs_Jfsfml0xpQSKk34pJA1TeC4dc8jGkI4As9Hx0cs5ZBqMBlSQCUKIYDPIFGASUjRYyqUSCaQxpGkgNlDfydPCU59LHKwKkRHY0VkcFNgdsAlk0lduLGQGTBqyEKwFXK28BjY7kGYdP1JpKIhBBoqQDGlHb8AKsOMgHWUOe_RomopQdvQk3Ris9DWnwm_bCPRBVPpDtVrKMGtrG927s2U89MURQ3O155aGnqOqSBjfYQKMCsSWfk8u1kt9-xDziExA3YyqNgmIgkZdfd1OazMM_vNs1Aag0VofSvxtpGKeeB-vc39EbGBw0BZZ8_rdjKk8UOUGc-4DjPM2wx_Ky2c0M7gc-5Uovx3hRQ9YG-mdxfWAGK7dI0ATbd53BKhQm_69B1oSjOvKS0FAlXeOBAm1GoHJylGb3yhd3xXS9F99Eta39GmvnYTyZjTnafdLBgi3f51da-Ze27Zu2w22MZvcZFf2mt0lt9gW__39fXiSlh9Pf7z58vPd6fLzh19fvy0_vb3NDsbZ_mg3ai4PiWZc4yTSJLL_7C3RlWrCi7ishEvEVDilSuEqrkvl4XPhuOFGJgRzpTSuFMOJMY6A3R22OT-aV3fZthbKuKpCURVTWbiSTJz3xopFEpd8OBH3mK6blb-qPcTk59Xe_QuX3GJX6--afjHwAdtcHJ9UDwkeL6aPwkj4A66KiMI
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=1%EF%BC%8ECrohn%E7%97%85%E3%81%AE%E5%86%85%E7%A7%91%E6%B2%BB%E7%99%82&rft.jtitle=%E6%97%A5%E6%9C%AC%E5%86%85%E7%A7%91%E5%AD%A6%E4%BC%9A%E9%9B%91%E8%AA%8C&rft.au=%E6%9D%BE%E6%9C%AC%2C+%E4%B8%BB%E4%B9%8B&rft.au=%E9%A3%AF%E7%94%B0%2C+%E4%B8%89%E9%9B%84&rft.au=%E5%8F%A4%E8%B3%80%2C+%E7%A7%80%E6%A8%B9&rft.date=2009&rft.pub=%E4%B8%80%E8%88%AC%E7%A4%BE%E5%9B%A3%E6%B3%95%E4%BA%BA+%E6%97%A5%E6%9C%AC%E5%86%85%E7%A7%91%E5%AD%A6%E4%BC%9A&rft.issn=0021-5384&rft.eissn=1883-2083&rft.volume=98&rft.issue=1&rft.spage=82&rft.epage=87&rft_id=info:doi/10.2169%2Fnaika.98.82&rft.externalDocID=article_naika_98_1_98_82_article_char_ja
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0021-5384&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0021-5384&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0021-5384&client=summon